57 related articles for article (PubMed ID: 11808338)
1. [Pharmacogenomics and pharmainformatics].
Tanaka T; Nishimura Y; Tsunoda H; Kitaoka Y; Naka M
Nihon Rinsho; 2002 Jan; 60(1):39-50. PubMed ID: 11808338
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic gene clusters as drug action mechanisms].
Tanaka T
Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():5P-7P. PubMed ID: 14727507
[TBL] [Abstract][Full Text] [Related]
3. [Transcriptome analysis and pharmacogenomics].
Tanaka T
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):241-6. PubMed ID: 11084921
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenomics: the frontiers of genome medicine].
Tanaka T; Tsujimoto G; Sugiyama Y; Hashimoto Y
Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):141-8. PubMed ID: 12271509
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics and therapeutic target validation in cerebral vasospasm.
Tanaka T; Nishimura Y; Tsunoda H; Naka M
J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S1-4. PubMed ID: 11206713
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models.
Tanaka T; Oka T; Shimada Y; Umemoto N; Kuroyanagi J; Sakamoto C; Zang L; Wang Z; Nishimura Y
J Pharmacol Sci; 2008 May; 107(1):8-14. PubMed ID: 18490853
[TBL] [Abstract][Full Text] [Related]
7. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
8. [Transcriptomes for serial analysis of gene expression].
Marti J; Piquemal D; Manchon L; Commes T
J Soc Biol; 2002; 196(4):303-7. PubMed ID: 12645300
[TBL] [Abstract][Full Text] [Related]
9. Genetics of type II diabetes.
Permutt MA; Chiu K; Ferrer J; Glaser B; Inoue H; Nestorowicz A; Stanley CA; Tanizawa Y
Recent Prog Horm Res; 1998; 53():201-16. PubMed ID: 9769709
[TBL] [Abstract][Full Text] [Related]
10. High throughput analysis of differential gene expression.
Carulli JP; Artinger M; Swain PM; Root CD; Chee L; Tulig C; Guerin J; Osborne M; Stein G; Lian J; Lomedico PT
J Cell Biochem Suppl; 1998; 30-31():286-96. PubMed ID: 9893282
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of human gastric cancer by transcriptome and proteome profiling].
Li W; Liu BY; Zhang XQ; Yang YQ; Li JF; Tang KL; Zhang QH; Chen XH; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):52-6. PubMed ID: 19145505
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 954 bovine full-CDS cDNA sequences.
Harhay GP; Sonstegard TS; Keele JW; Heaton MP; Clawson ML; Snelling WM; Wiedmann RT; Van Tassell CP; Smith TP
BMC Genomics; 2005 Nov; 6():166. PubMed ID: 16305752
[TBL] [Abstract][Full Text] [Related]
14. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage.
Onda H; Kasuya H; Takakura K; Hori T; Imaizumi T; Takeuchi T; Inoue I; Takeda J
J Cereb Blood Flow Metab; 1999 Nov; 19(11):1279-88. PubMed ID: 10566975
[TBL] [Abstract][Full Text] [Related]
15. The transcriptome's drugable frequenters.
Dechering KJ
Drug Discov Today; 2005 Jun; 10(12):857-64. PubMed ID: 15970268
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data.
Blower PE; Yang C; Fligner MA; Verducci JS; Yu L; Richman S; Weinstein JN
Pharmacogenomics J; 2002; 2(4):259-71. PubMed ID: 12196914
[TBL] [Abstract][Full Text] [Related]
17. [Genomic drug discovery and pharmainformatics].
Tanaka T; Nishimura Y; Tsunoda H; Naka M
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):805-10. PubMed ID: 10771637
[No Abstract] [Full Text] [Related]
18. Pharmacogenomic applications in clinical drug development.
Dracopoli NC
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S57-60. PubMed ID: 12856151
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Copy number variants and pharmacogenomics.
Ouahchi K; Lindeman N; Lee C
Pharmacogenomics; 2006 Jan; 7(1):25-9. PubMed ID: 16354122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
